Citadel Advisors »

Innate Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $39k 20k 1.95
2025-06-30 $47k 27k 1.75
2025-03-31 $43k 24k 1.78
2024-12-31 $22k 12k 1.85
2024-09-30 $49k 21k 2.29
2024-06-30 $46k 24k 1.94
2023-06-30 $42k 13k 3.14
2021-03-31 $109k 25k 4.32